Independent thinking for complex markets and current events
🚨 BREAKING: In a massive win, President Trump is set to launch TrumpRx to allow the purchase of discounted medications through cash. Trump will also announce an agreement for Pfizer to sell medications at LOWER PRICES through MEDICAID, per Reuters. HUGE. pic.twitter.com/rF85Zirc7i — Eric Daugherty (@EricLDaugh) September 30, 2025 Smells like a scam. Or like …
I agree, And all reality we should buy nothat has to do with drugs from China. It's all fake, just like everything they make. It looks good, but it doesn't last but a few days. And their vitamins and drugs are filled with heavy metals arsenic all kinds of chemicals — john pelarske (@JPelarske1957) December …
Millions of American seniors are having a hard time affording their prescription medications, a new National Health Statistics report suggests. The study, published by the Centers for Disease Control and Prevention, found that approximately 4% of those aged 65 and older can’t afford their prescription at all, and more than 3% of them skipped doses, …
It should be interesting to see how the consumer sector is impacted by this trend. In an inflationary environment with more focus on health, spending will shift. Another long-term trend that is worth watching. Follow us @KobeissiLetter for real time analysis as this develops. — The Kobeissi Letter (@KobeissiLetter) October 11, 2023 Why is there …